Clinical trial Recruiting at 1 site Observational Ages 8 to 18

Wearable remote monitoring for pediatric heart failure patients

Official title: There's No Place Like Home…Feasibility of Remote Physiological Monitoring in Childhood Heart Failure

Run by University of Alberta · NCT06969560 · Data updated 2026-11-12

This study is testing a new wearable device that helps track the health of kids with heart failure to see if it can improve their care at home and reduce hospital visits.

More Heart Failure trials

Quick facts

Study typeObservational
Ages8 Years to 18 Years
SexAll
Enrollment100 (estimated)
SponsorUniversity of Alberta
Academic / other
Drugs / interventionschemotherapy
Locations4 sites (Edmonton, Alberta and 3 other locations)
StatusRecruiting
StartedFebruary 24, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2028
Registry record updatedMay 11, 2026
Trial IDNCT06969560 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pediatric outpatients aged 8-18 with or at risk of deteriorating heart failure.

Probably not a fit

Patients who are not outpatients or do not meet the specified age and health criteria may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on the use of wearable remote physiologic monitoring (RPM) technology to track the health of pediatric patients with heart failure or those at risk of developing it. By enrolling 100 outpatients aged 8-18 from four tertiary pediatric heart failure centers in Canada, the study aims to utilize a Bluetooth-enabled textile device to monitor vital signs such as heart rate, respiratory rate, and blood pressure. The goal is to improve home-based care and reduce reliance on hospital visits, particularly for vulnerable populations. The study will also explore the integration of machine learning algorithms to predict health deterioration based on collected data.

Why it matters

Potential benefit: If successful, this approach could provide safer, more equitable home-based care for children with heart failure.

How similar studies have gone: While RPM has been successful in adult populations, this approach is novel and untested in pediatric heart failure care.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients from 8-18 years of age who are outpatients at time of study enrollment.
* Patients with a chest size of at least 69.85 cm in perimeter/circumference (as measured under the pectoral muscles)
* Patients at-risk for heart failure and with American Heart Association (AHA) Stage B-D Heart Failure will be included in this study irrespective of heart failure medication use.
* HF etiologies include: congenital cardiac malformation with systemic ventricular systolic dysfunction, idiopathic cardiomyopathy, familial/inherited and/or genetic cardiomyopathy, history of myocarditis with persistent ventricular dysfunction, neuromuscular disorder, inborn error of metabolism, mitochondrial disorder, acquired (chemotherapy, iatrogenic, infection, rheumatic, or nutritional), ischemic (e.g., Kawasaki disease and post-operative HF), and left ventricular non-compaction, restrictive cardiomyopathy and HCM with systolic or diastolic dysfunction.

Exclusion Criteria:

* Patients within 3 months of a surgery.
* Patients supported by ventricular assist device at study onset.
* Inability to use technology due to physical or cognitive impairment in the patient or caregiver.
* Non-English speaking.
* Patients who have an implantable cardiac defibrillator or pacemaker
* Patients whose chest size is too large or small to fit available sizes of the Skiin device.

Where it's running

  • Stollery Children's Hospital
    Edmonton, Alberta, Canada
    Recruiting
  • BC Children's Hospital
    Vancouver, British Columbia, Canada
    Not yet recruiting
  • The Hospital for Sick Children
    Toronto, Ontario, Canada
    Not yet recruiting
  • CHU Sainte-Justine
    Montreal, Quebec, Canada
    Not yet recruiting

Study contacts

  • Principal investigator: Jennifer L Conway, MD, MSc — University of Alberta/Stollery Children's Hospital
  • Study coordinator: Jennifer L Conway, MD, MSc
  • Email: jennifer.conway2@ahs.ca
  • Phone: 780-407-4848

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.